A new drug which allegedly treats Breast cancer has been approved by the FDA. The drug was said to have cured breast cancer caused by the BRCA mutation, which Angelina Jolie famously attributed to her preventive double mastectomy.
The drug named Lynparza according to a press release by the Food and Drug Administration was approved for patients whose breast cancer has metastasized and who carry a mutation in the BRCA1 and BRCA2 genes.
The genes’ helps the body repair damaged DNA and also makes sure to keep cells in good working order. When those genes don’t function properly, the probability of a woman developing breast or ovarian cancer is increased.
Angelina Jolie who carries “faulty” gene inherited from her mother, who died of cancer at age 56, wrote, “My doctors estimated that I had an 87 percent risk of breast cancer and a 50 percent risk of ovarian cancer, although the risk is different in the case of each woman.
“Only a fraction of breast cancers result from an inherited gene mutation. Those with a defect in BRCA1 have a 65 percent risk of getting it, on average.”
She Described the eight-hour procedure to remove breast tissue as a “scene out of a science-fiction film,” Jolie wrote
“On a personal note, I do not feel any less of a woman. I feel empowered that I made a strong choice that in no way diminishes my femininity.”